Evidence map›Paper›PMID 19301905›Full record

ArticleBioconjugate chemistry2009

Comparative methods for analysis of protein covalent modification by electrophilic quinoids formed from xenobiotics.

Bolan Yu, Zhihui Qin, Gihani T Wijewickrama, Praneeth Edirisinghe, Judy L Bolton, Gregory R J Thatcher

Open access · greenAbstract readComparative Study
In one paragraph

Article in Bioconjugate chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Gold-Based Pharmacophore Inhibits Intracellular MYC Protein.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Bolan YuDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, 60612, USA.
Zhihui Qin
Gihani T Wijewickrama
Praneeth Edirisinghe
Judy L Bolton
Gregory R J Thatcher
University of Illinois Chicago · US

Funding

CARCINOGENIC METABOLITES FORMED FROM ANTIESTROGENSR01CA079870 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BOLTON, JUDY L · 1999 to 2013
$2.9M
Biointeractions of Antiestrogens with Nitric OxideR01CA102590 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI THATCHER, GREGORY R. J · 2005 to 2015
$2.2M
Nitric Oxide Chimera Drugs for Colon Cancer ChemopreventionR01CA121107 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI THATCHER, GREGORY R. J · 2008 to 2012
$1.6M
Carcinogenic Metabolites Formed from AntiestrogensR56CA079870 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BOLTON, JUDY L · 2008 to 2008
$216k
NCI NIH HHS CA 102590NCI NIH HHS CA 121107NCI NIH HHS CA 79870NCI NIH HHS R01 CA102590NCI NIH HHS R01 CA121107
6 · The paper itself

Abstract

Conjugation of biotin and fluorophore tags is useful for assaying covalent protein modification. Oxidative bioactivation of selective estrogen receptor modulators (SERMs) yields reactive quinoid electrophiles that covalently modify proteins, and bioactivation is associated with carcinogenic and chemopreventive effects. Identification of the protein targets of electrophilic metabolites is of general importance for xenobiotics. Four methodologies using SERM derivatized biotin/fluorophore tags were compared for purification and quantification: (1) covert oxidatively activated tags (COATags; SERM conjugated to biotin); (2) dansylTags (SERM conjugated to fluorophore); and azidoTags (SERM azide derivatives) in a two-step conjugation to biotin, using either (3) Staudinger ligation or (4) click chemistry. All synthetic derivatives retained the estrogen receptor ligand characteristics of the parent SERMs. Model proteins with bioactivation by tyrosinase in buffer or cell lysates and liver proteins with in situ bioactivation in rat primary hepatocytes were studied by immunoassay and fluorescence. Comparison showed that the azidoTag/Staudinger method was sensitive but nonspecific, the azidoTag/click methodology had low sensitivity, and the dansylTag methodology failed to detect modified proteins in hepatocytes. The COATag methodology was judged superior, detecting 5 ng of modified protein in vitro and identifying protein targets in hepatocytes. In metabolism studies in rat liver microsomes, the azide group was metabolically labile, which was a contributing factor in not selecting the azidoTag methodology in the oxidative environments required for bioactivation. For study of the protein targets of electrophilic metabolites formed by in situ oxidative bioactivation, the COATag is both sensitive and specific and does not appear to suffer from poor cell permeability.

Indexed as

AnimalsAzidesBiotinylationCell ExtractsCell Line, TumorHepatocytesIndicators and ReagentsLigandsMass SpectrometryOxidation-ReductionPiperidinesProteinsQuinonesRaloxifene HydrochlorideRatsReceptors, EstrogenAzidesCell ExtractsIndicators and ReagentsLigandsLY 353381PiperidinesProteinsQuinonesRaloxifene HydrochlorideReceptors, EstrogenSelective Estrogen Receptor ModulatorsThiophenesXenobiotics

Identifiers

PMID19301905
PMCPMC2827204
OpenAlexW2032431893

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.